| The effect of recent amblyopia research on current practice in the UK. | |
| | |
MedLine Citation:
|
PMID: 20576776 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND/AIMS: Several studies have recently provided insights into how amblyopia may be most effectively managed. Despite the new evidence, a US study reported that a recent randomised controlled trial had made little influence on clinical practice. The aims of this research are to assess current practice of amblyopia management in the UK and to determine the comparability with the evidence-based recommendations. METHODS: A questionnaire was constructed to assess current amblyopia management practice, particularly in relation to areas investigated by recent research and emailed to every head orthoptist within the UK. RESULTS: There was a great deal of variability in the amount of occlusion that was prescribed for moderate and severe amblyopia. Sixty per cent of clinicians indicated that the maximum they would prescribe was in excess of the 6 h recommended by research. Atropine was rarely recommended as a first-line treatment, with occlusion generally being considered to be more effective. Despite recommendations regarding education as a means of reducing non-compliance, only 39% of clinicians always gave written information, although various other methods of enhancing compliance were used. A period of refractive adaptation was allowed by most clinicians but often far less than recommended. CONCLUSION: The uptake of recent research evidence into clinical practice is sporadic and incomplete with one-third of respondents indicating that following the studies, they had made no changes whatsoever to their practice. This is similar to other areas of medicine; the reasons are likely to be varied, and is an area that would benefit from greater attention. |
| | |
Authors:
|
D Newsham |
Related Documents
:
|
22161386 - Catheter policies for management of long term voiding problems in adults with neurogeni... 12733686 - Canadian perspectives in glaucoma management: setting target intraocular pressure range. 17033146 - Evidence-based medicine for neurosurgeons: introduction and methodology. 17952106 - Access to essential medicines for children: the world health organization's global resp... 22107156 - Managed approaches to multiple sclerosis in special populations. 17567336 - Hippocratic messages for modern medicine (the vindication of hippocrates). |
Publication Detail:
|
Type: Journal Article; Multicenter Study Date: 2010-06-24 |
Journal Detail:
|
Title: The British journal of ophthalmology Volume: 94 ISSN: 1468-2079 ISO Abbreviation: Br J Ophthalmol Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-10-07 Completed Date: 2010-12-06 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0421041 Medline TA: Br J Ophthalmol Country: England |
Other Details:
|
Languages: eng Pagination: 1352-7 Citation Subset: IM |
Affiliation:
|
School of Health Sciences, University of Liverpool, Thompson Yates Building, Liverpool, UK. d.newsham@liv.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Amblyopia / therapy* Atropine / therapeutic use Child Evidence-Based Medicine Great Britain Humans Mydriatics / therapeutic use Orthoptics* Patient Compliance Patient Education as Topic Professional Practice* Questionnaires Sensory Deprivation Visual Acuity |
| Chemical | |
Reg. No./Substance:
|
0/Mydriatics; 51-55-8/Atropine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Transscleral diode laser cycloablation in patients with good vision.
Next Document: Retinal nerve fibre layer evaluation in ocular hypertensive eyes using optical coherence tomography ...